Key statistics
On Friday, Edgewise Therapeutics Inc (EWTX:NSQ) closed at 28.28, -5.73% below its 52-week high of 30.00, set on Sep 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 29.94 |
---|---|
High | 29.94 |
Low | 27.76 |
Bid | 27.71 |
Offer | 29.98 |
Previous close | 29.50 |
Average volume | 2.62m |
---|---|
Shares outstanding | 93.77m |
Free float | 93.33m |
P/E (TTM) | -- |
Market cap | 2.65bn USD |
EPS (TTM) | -1.53 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Edgewise Therapeutics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM)
- Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Data from Phase 1 trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM) on Thursday, September 19 at 8:30 am Eastern Time
- Edgewise Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights